SPX3,948.75-15.19 -0.38%
DIA337.54-0.95 -0.28%
IXIC10,987.26-62.24 -0.56%

12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga · 11/15/2022 12:32

Gainers

  • SenesTech (NASDAQ:SNES) stock increased by 113.6% to $0.31 during Tuesday's regular session. Trading volume for SenesTech's stock is 36.2 million as of 12:30 EST. This is 4720.6% of its average full-day volume over the last 100 days. The company's market cap stands at $3.7 million. As per the press release, Q3 earnings came out yesterday.
  • Tenax Therapeutics (NASDAQ:TENX) shares increased by 60.73% to $0.15. As of 12:30 EST, this security is trading at a volume of 48.0 million shares, making up 3073.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.6 million. The company's, Q3 earnings came out 3 days ago.
  • Exagen (NASDAQ:XGN) shares moved upwards by 34.76% to $2.83. Trading volume for Exagen's stock is 149.4K as of 12:30 EST. This is 520.2% of its average full-day volume over the last 100 days. The company's market cap stands at $46.0 million. As per the news, the Q3 earnings report came out yesterday.
  • Calyxt (NASDAQ:CLXT) stock moved upwards by 32.97% to $0.2. Calyxt's stock is trading at a volume of 1.8 million shares as of 12:30 EST. This is 515.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $9.7 million.
  • Azenta (NASDAQ:AZTA) shares moved upwards by 28.72% to $59.96. As of 12:30 EST, this security is trading at a volume of 2.7 million shares, making up 351.9% of its average full-day volume over the last 100 days. The company's market cap stands at $4.4 billion. As per the news, the Q4 earnings report came out yesterday.
  • Gelesis Holdings (NYSE:GLS) shares increased by 28.25% to $0.47. As of 12:30 EST, Gelesis Holdings's stock is trading at a volume of 101.6K, which is 72.3% of its average full-day volume over the last 100 days. The company's market cap stands at $34.0 million. As per the news, the Q3 earnings report came out yesterday.

Losers

  • Lucira Health (NASDAQ:LHDX) shares declined by 34.0% to $0.48 during Tuesday's regular session. Trading volume for Lucira Health's stock is 864.3K as of 12:30 EST. This is 1747.9% of its average full-day volume over the last 100 days. The company's market cap stands at $19.3 million. As per the press release, Q3 earnings came out yesterday.
  • TFF Pharmaceuticals (NASDAQ:TFFP) shares decreased by 25.0% to $1.11. As of 12:30 EST, this security is trading at a volume of 554.1K shares, making up 360.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $28.2 million. As per the press release, Q3 earnings came out yesterday.
  • Minerva Surgical (NASDAQ:UTRS) stock declined by 24.89% to $0.22. Trading volume for Minerva Surgical's stock is 239.6K as of 12:30 EST. This is 202.4% of its average full-day volume over the last 100 days. The company's market cap stands at $6.3 million. As per the news, the Q3 earnings report came out yesterday.
  • Assure Hldgs (NASDAQ:IONM) stock decreased by 23.92% to $0.53. Assure Hldgs's stock is trading at a volume of 177.1K shares as of 12:30 EST. This is 53.1% of its average full-day volume over the last 100 days. The company's market cap stands at $9.7 million. As per the news, the Q3 earnings report came out yesterday.
  • Daxor (NASDAQ:DXR) stock decreased by 20.46% to $9.45. As of 12:30 EST, this security is trading at a volume of 82.2K shares, making up 1800.0% of its average full-day volume over the last 100 days. The company's market cap stands at $38.1 million.
  • Neoleukin Therapeutics (NASDAQ:NLTX) stock declined by 20.44% to $0.42. Neoleukin Therapeutics's stock is trading at a volume of 474.2K shares as of 12:30 EST. This is 254.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $17.9 million. The company's, Q3 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.